PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,273,656 | +53.1% | 400,054 | +100.0% | 0.03% | -15.6% |
Q2 2023 | $8,015,082 | -1.8% | 200,027 | 0.0% | 0.03% | -5.9% |
Q1 2023 | $8,163,102 | +5.7% | 200,027 | 0.0% | 0.03% | -2.9% |
Q4 2022 | $7,723,042 | -46.2% | 200,027 | -25.9% | 0.04% | -52.7% |
Q3 2022 | $14,363,000 | -8.8% | 270,027 | 0.0% | 0.07% | -3.9% |
Q2 2022 | $15,743,000 | -27.6% | 270,027 | -5.3% | 0.08% | -14.4% |
Q1 2022 | $21,753,000 | +39.6% | 285,027 | +10.1% | 0.09% | +57.9% |
Q4 2021 | $15,580,000 | +39.1% | 258,936 | +29.5% | 0.06% | +23.9% |
Q3 2021 | $11,202,000 | +8.6% | 200,027 | +17.6% | 0.05% | +2.2% |
Q2 2021 | $10,317,000 | +17.8% | 170,027 | +36.0% | 0.04% | 0.0% |
Q1 2021 | $8,761,000 | – | 125,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |